___

• 1. Shih SR, Chiu WY, Chang TC, Tseng CH. Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res 2012;2012:578285.
• 2. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep 2017;7(1):13461.
• 3. Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 2011;17(4):616−28.
• 4. Chen Y, Zhu C, Chen Y, Wang N, Li Q, Han B, et al. The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study. Int J Endocrinol 2018;2018:6853617.
• 5. Mansour A, Mohammed MA, Anwar R, Elzafrany M, Omar NM. AB0 blood group and risk of malignancies in Egyptians. Int J Cancer Res 2014;10(2):81−95.
• 6. Tam AA, Özdemir D, Fakı S, Bilginer MC, Ersoy R, Çakır B.ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To ‘B’ or Not to ‘B’. Endocr Res. 2019 Nov 25:1-10. doi: 10.1080/07435800.2019.1695261. [Epub ahead of print]
• 7. Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, et al. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol 2012;18(6):563−9.
• 8. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15(6):548−55.
• 9. Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6(11):863−73.
• 10.Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A, et al. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 2010;21(6):879−87.
• 11.Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, et al. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 2011;21(9):957−63.
• 12.Yeo Y, Ma SH, Hwang Y, Horn-Ross PL, Hsing A, Lee KE, et al. Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis. PLOS ONE 2014;9(6):e98135.
• 13.Li H, Qian J. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies. Medicine(Baltimore) 2017;96(47):e8230.
• 14.Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009;161(4):599−605.
• 15.Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008;18(4):461−4.
• 16.Zivaljevic V, Slijepcevic N, Paunovic I, Diklic A, Kalezic N, Marinkovic J, et al. Risk Factors for Anaplastic Thyroid Cancer. Int J Endocrinol 2014;2014:6.
• 17.Seo YG, Choi HC, An AR, Park DJ, Park YJ, Lee KE, et al. The Association between Type 2 Diabetes Mellitus and Thyroid Cancer. J Diabetes Res 2017;2017:5850879.
• 18.Ewald DR, Sumner SCJ. Blood Type Biochemistry and Human Disease. Wiley Interdiscip Rev Syst Biol Med 2016;8(6):517−35.
• 19.Akhtar K, Mehdi G, Sherwani R, Sofi L. Relationship between various cancers and ABO blood groups–A Northern India experience. Int J Pathol 2010;13(1):3−7.
• 20.Jin T, Li PJ, Chen XZ, Hu WH. ABO blood group is a predictor of survival in patients with laryngeal cancer. Chin J Cancer 2016;35(1):90.
• 21.Sheng L, Sun X, Zhang L, Su D. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 2013;133(4):893−7.